Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
一项开放标签的 II 期前瞻性、随机、对照研究，旨在评估 Romyelocel-L 髓系祖细胞在急性髓系白血病诱导化疗期间降低感染风险的疗效。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.01739
Desai, Pinkal M; Brown, Janice; Gill, Saar; Solh, Melham M; Akard, Luke P; Hsu, Jack W; Ustun, Celalettin; Andreadis, Charalambos; Frankfurt, Olga; Foran, James M; Lister, John; Schiller, Gary J; Wieduwilt, Matthew J; Pagel, John M; Stiff, Patrick J; Liu, Delong; Khan, Irum; Stock, Wendy; Kambhampati, Suman; Tallman, Martin S; Morris, Lawrence; Edwards, John; Pusic, Iskra; Kantarjian, Hagop M; Mamelok, Richard; Wong, Alicia; Van Syoc, Rodney; Kellerman, Lois; Panuganti, Swapna; Mandalam, Ramkumar; Abboud, Camille N; Ravandi, Farhad
